American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes

March 7, 2019 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

September 28, 2017 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

September 28, 2017 Meeting Minutes

Joint meeting of the Analytical Laboratories, Botanical Raw Materials, And Standards Committees

AHPA Members log in to download the meeting minutes.
RSS
12

Committee-Related News

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.

AHPA urges USTR to exempt herbal product ingredients from proposed China tariff increases

Herbal ingredients should be excluded from tariff increases because supplements and food play important roles in the health of U.S. consumers

The American Herbal Products Association (AHPA) urged the U.S. Trade Representative (USTR) to remove herbal product ingredients from a list of Chinese goods that would be subject to a 25 percent ad valorem duty under a recent USTR proposal to increase tariffs on an estimated $300 billion worth of Chinese imports.
More than 30 AHPA members and staff participate in the 2019 Day on the Hill

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

AHPA partners with CRN, CHPA and UNPA to produce this unique advocacy opportunity

More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

McGuffin recommends FDA issue interim final rule with an accelerated effective date

American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.
AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA provides expertise in hemp-CBD, regulatory initiatives, pesticide residues, NDIs and food allergens

U.S. increases and proposes expansion of tariffs on Chinese imports

China announces additional tariffs on any plant mainly used as a spice

The U.S. Trade Representative (USTR) announced on May 9 that it increased tariffs on approximately $200 billion worth of Chinese imports initially identified in September 2018 from 10 percent to 25 percent.

AHPA urges specificity in OEHHA review of scientific data on cannabis

Scientific review should be specific to route of consumption and part of the plant

In a letter to California’s Office of Environmental Health Hazard Assessment (OEHHA), AHPA strongly recommends that the office ensures that the Developmental and Reproductive Toxicant Identification Committee (DARTIC) sufficiently differentiates between the parts of the cannabis plant and the route of exposure when it reviews scientific literature to determine if certain cannabis articles should be listed under Proposition 65 as causing reproductive toxicity.

AHPA adopts Guidance Policy on supplements and foods containing hemp and hemp-derived CBD

Supplements or foods that contain hemp or CBD should be manufactured in compliance with applicable federal regulations

The American Herbal Products Association (AHPA) has adopted a new Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD) to help ensure the industry complies with existing regulations.

AHPA Events at SupplySide West

Mandalay Bay Convention Center -- Las Vegas

Join AHPA for committee meetings, member reception and the Botanical Congress
RSS
123456